SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,225 | -78.3% | 235,000 | -86.0% | 0.00% | -75.0% |
| Q3 2022 | $471,000 | -22.1% | 1,680,536 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $605,000 | -46.3% | 1,680,536 | -0.1% | 0.01% | -66.7% |
| Q1 2022 | $1,127,000 | -51.5% | 1,682,000 | -6.6% | 0.02% | -37.5% |
| Q4 2021 | $2,322,000 | -36.3% | 1,800,000 | +7.1% | 0.02% | -51.0% |
| Q3 2021 | $3,646,000 | -13.3% | 1,680,000 | +9.1% | 0.05% | -3.9% |
| Q2 2021 | $4,204,000 | +0.7% | 1,540,000 | -3.8% | 0.05% | 0.0% |
| Q1 2021 | $4,176,000 | -53.1% | 1,600,000 | -50.0% | 0.05% | +6.2% |
| Q4 2020 | $8,896,000 | – | 3,200,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 310,500 | $863,000 | 1.79% |
| Consonance Capital Management LP | 3,186,335 | $8,858,000 | 0.83% |
| Opaleye Management Inc. | 2,000,000 | $5,560,000 | 0.73% |
| Sio Capital Management, LLC | 886,665 | $2,465,000 | 0.50% |
| Rubric Capital Management LP | 2,335,200 | $6,492,000 | 0.48% |
| Affinity Asset Advisors, LLC | 250,000 | $695,000 | 0.37% |
| GSA CAPITAL PARTNERS LLP | 354,265 | $985,000 | 0.16% |
| Hudson Bay Capital Management LP | 3,200,000 | $8,896,000 | 0.05% |
| Insight Advisors, LLC/ PA | 24,000 | $67,000 | 0.02% |
| Maven Securities LTD | 86,788 | $246,000 | 0.02% |